NOVAVAX INC Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2020-11-10: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2020-08-10: Form 10-Q; Item Stock registered under Section 12(b); As filed Common Stock, Par Value $0.01 per share · NVAX · NASDAQ.
- 2020-08-10: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2020-05-11: Form 10-Q; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2020-11-10 | 10-Q | Smaller reporting company | Yes |
| 2020-08-10 | 10-Q | Stock registered under Section 12(b) | Common Stock, Par Value $0.01 per share · NVAX · NASDAQ |
| 2020-08-10 | 10-Q | Smaller reporting company | Yes |
| 2020-05-11 | 10-Q | Smaller reporting company | Yes |
| 2020-03-11 | 10-K | Smaller reporting company | Yes |
| 2019-11-07 | 10-Q | Smaller reporting company | Yes |
| 2019-08-07 | 10-Q | Smaller reporting company | Yes |
| 2019-05-02 | 10-Q | Smaller reporting company | Yes |
| 2019-03-18 | 10-K | Smaller reporting company | Yes |
| 2019-03-18 | 10-K | Well-known seasoned issuer | No |
| 2018-03-14 | 10-K | Well-known seasoned issuer | No |
| 2017-02-27 | 10-K | Well-known seasoned issuer | No |
| 2013-03-12 | 10-K | Well-known seasoned issuer | No |
| 2012-03-14 | 10-K | Well-known seasoned issuer | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |